This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Regeneron Pharmaceuticals, Inc., Sanofi Biotechnology. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,479 
2 out of 40 
Years Active: 2022-2025
Title: Jerome Msihid - Innovator in Pharmaceutical Research
Introduction
Jerome Msihid is a notable inventor based in Paris, France. He currently works at Sanofi-Aventis Deutschland GmbH, a leading global healthcare company. Although he has not yet been granted any patents, his contributions to pharmaceutical research are significant.
Latest Patent Applications
Jerome's latest patent applications include:
1. **GLP-1 Agonist for Use in the Treatment of Stenosis or/and Obstruction in the Biliary Tract** - This invention relates to a pharmaceutical composition aimed at treating conditions associated with stenosis or obstruction in the biliary tract, utilizing at least one GLP-1 agonist along with a pharmaceutically acceptable carrier, diluent, or auxiliary substance.
2. **GLP-1 Agonist for Use in the Treatment of Stenosis or/and Obstruction in the Pancreatic Duct System** - Similar to the previous application, this invention focuses on a pharmaceutical composition for treating stenosis or obstruction in the pancreatic duct system, also incorporating at least one GLP-1 agonist and optional carriers or substances.
Conclusion
Jerome Msihid is an emerging inventor in the field of pharmaceuticals, with promising applications that could lead to significant advancements in treatment options. His work at Sanofi-Aventis Deutschland GmbH highlights his commitment to innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile